Jenniskens, Josien C. A. http://orcid.org/0000-0003-2727-2981
Offermans, Kelly http://orcid.org/0000-0001-6842-4887
Simons, Colinda C. J. M. http://orcid.org/0000-0002-0085-5186
Samarska, Iryna http://orcid.org/0000-0003-4092-0672
Fazzi, Gregorio E. http://orcid.org/0000-0001-7068-8435
van der Meer, Jaleesa R. M.
Smits, Kim M. http://orcid.org/0000-0002-4629-4396
Schouten, Leo J. http://orcid.org/0000-0003-3361-7560
Weijenberg, Matty P. http://orcid.org/0000-0003-1695-4768
Grabsch, Heike I. http://orcid.org/0000-0001-9520-6228
van den Brandt, Piet A. http://orcid.org/0000-0001-8781-8099
Funding for this research was provided by:
KWF Kankerbestrijding (11044)
Article History
Received: 13 January 2022
Accepted: 6 April 2022
First Online: 11 May 2022
Declarations
:
: H. I. Grabsch: Honorarium from Astra Zeneca and BMS for scientific advisory board activities not related to the current study.
: Ethical approval was obtained from Medical Ethical Committee MUMC.
: Individuals consented to participate in the NLCS by completing and returning the questionnaire.
: Not applicable.